ZBH - Zimmer Biomet Holdings, Inc.

ZBH

$82.33 0.49 (-0.59%) Last updated: May 31, 2026 02:02

52-Week Range

$82.33

$79.12 $82.33 $108.29

Fundamentals Overview

Zimmer Biomet Holdings, Inc. is near the low of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 21.2 P/B 1.09 P/S 1.89

Intrinsic value (DCF)

+556.6% upside vs price

Profitability

Net margin 9.1%

Risk (Beta)

0.47 — lower vol

Earnings & growth

EPS $3.89 Rev -7% Profit +70.7% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 56% confidence Risk: Lower Volatility — Beta 0.47. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +556.6% upside vs price · Analyst grade: A-

Pressures (Sell):

Sentiment weakening (3 downgrades) · 3M vs S&P 500: -26.7% · 3M vs Healthcare sector: -12.2%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$15.93B

P/E (TTM)

21.17

EPS (TTM)

$3.89

Dividend Yield

1.17%

52-Week Range

$79.12 - $108.29

Volume vs Avg

N/A

Beta

0.47

About

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconst...

Sector: Healthcare

Headquarters: US

Employees: 17,000

IPO Date: Jul 2001

Website: www.zimmerbiomet.com

Beta: 0.47 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 5, Equal Weight: 2, Hold: 4, In Line: 1, Market Outperform: 1, Market Perform: 1, Neutral: 8, Outperform: 2, Sell: 2, Underweight: 4.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $540.58; current price is $82.33. That’s a +556.6% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	21.17
DCF value (model)	$540.58 (556.6% upside)
PEG (TTM)	N/A
P/B (TTM)	1.09
P/S (TTM)	1.89
P/FCF (TTM)	8.68
Liquidity & enterprise
Current Ratio (TTM)	2.94
Quick Ratio (TTM)	1.61
Cash Ratio (TTM)	0.25
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	9.05%
Gross margin (TTM)	70.03%
Operating margin (TTM)	15.61%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ZBH.

Analyst Sentiment at a Glance

A- Sentiment Weakening

Buy 5Equal Weight 2Hold 4In Line 1Market Outperform 1Market Perform 1Neutral 8Outperform 2Sell 2Underweight 4

1 upgrade, 3 downgrades

Price Target Consensus

Current $82.33

Median $93.00

Consensus $96.33

Low consensus $83.00

High consensus $120.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Citigroup	maintain	Neutral	Neutral	2026-05-28
Citigroup	maintain	Neutral	Neutral	2026-04-29
Stifel	maintain	Buy	Buy	2026-04-29
Truist Securities	maintain	Hold	Hold	2026-04-29
JP Morgan	maintain	Neutral	Neutral	2026-04-29
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-04-29
Citizens	maintain	Market Outperform	Market Outperform	2026-04-29
Barclays	maintain	Underweight	Underweight	2026-04-29
BTIG	downgrade	Buy	Neutral	2026-03-23
Barclays	maintain	Underweight	Underweight	2026-02-12
Citigroup	maintain	Neutral	Neutral	2026-02-11
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-02-11
Needham	maintain	Hold	Hold	2026-02-10
BTIG	maintain	Buy	Buy	2026-02-10
UBS	maintain	Sell	Sell	2026-01-28
Bernstein	maintain	Market Perform	Market Perform	2026-01-09
BTIG	maintain	Buy	Buy	2026-01-08
Evercore ISI Group	upgrade	In Line	Outperform	2026-01-05
Baird	downgrade	Outperform	Neutral	2025-12-16
Citigroup	maintain	Neutral	Neutral	2025-12-11
Canaccord Genuity	maintain	Hold	Hold	2025-11-10
Barclays	maintain	Underweight	Underweight	2025-11-06
UBS	maintain	Sell	Sell	2025-11-06
JP Morgan	downgrade	Overweight	Neutral	2025-11-06
RBC Capital	maintain	Outperform	Outperform	2025-11-06
BTIG	maintain	Buy	Buy	2025-11-05
Barclays	maintain	Underweight	Underweight	2025-11-05
Canaccord Genuity	maintain	Hold	Hold	2025-10-22
BTIG	maintain	Buy	Buy	2025-10-13
Evercore ISI Group	maintain	In Line	In Line	2025-10-07